ATG16L1 and colitis: Studies in mice with myeloid ATG16L1 deficiency have shown that ATG16L1 deficiency leads to an increased inflammatory response as well as an increase in colitis-causing bacteria, suggesting that ATG16L1 deficiency leads to altered macrophage function, which exacerbates CD (67).